Adamant Biomedical Investments AG: BKD position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Adamant Biomedical Investments AG on BKD, newest first. How the timeline and the estimate are built.

Adamant Biomedical Investments AG held 129,540 BKD shares at 2014-12-31 per its 13F-HR filed 2015-02-13.

the latest 13F is the newest step

period ended2014-12-31
13F 129,540 shares
Change vs previous 13F -8,080 shares
1.14% of the 13F portfolio, value $4,750,000.
13F-HR 0000950123-15-002090 filed by Adamant Biomedical Investments AG
Filed 2015-02-13 (acceptance time not in the bulk data set), ingested 2026-10-07 19:17:13 UTC
Acceptance time not in the bulk data set (spec §4.2).
period ended2014-09-30
13F 137,620 shares
Change vs previous 13F not available
1.11% of the 13F portfolio, value $4,434,000.
13F-HR 0000950123-14-012192 filed by Adamant Biomedical Investments AG
Filed 2014-11-14 (acceptance time not in the bulk data set), ingested 2026-10-07 19:26:03 UTC
Acceptance time not in the bulk data set (spec §4.2).